6 Early-Stage Surgical Technology Startups to Watch

Why AltuSafe stands out

A signed surgical checklist is not the same as a completed conversation among the people performing an operation. AltuSafe focuses on this execution gap. Its premise is that safety procedures are only useful when the team performs and documents critical checks, rather than treating them as an administrative formality.

What AltuSafe is building

AltuSafe is developing an operating-room workflow around structured surgical safety checks and teamwork. Its stated approach draws a distinction between a checklist recorded as complete and actions actually carried out together. Its practical value will depend on how consistently surgical teams can complete these checks without adding documentation burden.

Why ClearSurgery stands out

Operating rooms can contain several displays and distinct data sources, making it hard to keep relevant information directly in view. ClearSurgery approaches that problem through spatial computing, the placement and manipulation of digital information within a three-dimensional visual environment. Its value proposition is an interface that follows the surgeon rather than requiring the surgeon to work around fixed screens.

What ClearSurgery is building

ClearSurgery is developing ClearSphere, an immersive visualization workspace for surgical video and patient information, supported by connected video hardware. It brings feeds and digital materials into a personal field of view and allows natural interactions. Integration with hospital imaging sources and usability during procedures will be important to adoption.

Why Slow Surg stands out

Slow Surg brings a therapeutic approach rather than a software layer. Its MAGUS technology originates in research on digestive-tract pouches that can cause retained food and symptoms after certain operations. In a pre-spinout series involving 14 patients, symptom scores improved at three months.

The startup is a 2025 spin-off of the Université libre de Bruxelles. The underlying development includes clinician involvement at Erasme Hospital, linking the device concept to the team treating the problem.

What Slow Surg is building

MAGUS is an endoscopically placed magnetic device. Therapeutic endoscopy uses a flexible instrument passed through the digestive tract to deliver treatment without conventional open surgery. The paired magnetic components gradually divide a tissue partition to allow a pouch to communicate with the main digestive passage. The MAGUS-CCS clinical study began in 2023 with a target enrollment of 51 patients, extending the development program beyond the initial patient series.

Why UnVeil Surgical stands out

Navigation can matter most where a small positioning error could affect delicate structures. In ear, nose and throat surgery, the challenge is not simply obtaining images but aligning those images with the patient and keeping that alignment useful during the procedure. UnVeil Surgical focuses on simplifying this image-registration step for teams that cannot afford lengthy setup.

What UnVeil Surgical is building

UnVeil Surgical is developing a compact navigation platform intended to combine planning, automated registration and intraoperative guidance. Surgical navigation connects instrument position with anatomical images; image registration is the process of aligning those images to the patient. The platform aims to make those steps less cumbersome, with clinical adoption depending on accuracy, reliability, manageable training requirements and compatibility with existing operating rooms.

Why IMPLANZ stands out

Dental implant stability depends partly on the fit between the implant and the patient’s jawbone. IMPLANZ starts before surgery, using simulations to make that decision less dependent on imaging alone. Founder-linked studies on cadaveric implants and jawbone specimens found that simulation outputs predicted mechanical failure loads more closely than some conventional measures. The results establish an early laboratory evidence base rather than demonstrating improvements in patient outcomes.

The startup is a University of Bern ARTORG spinout. IMPLANZ and ARTORG received an Innosuisse-supported innovation project for implant-planning technology, while co-founder Christoph Rickert has prior startup-exit experience.

What IMPLANZ is building

IMPLANZ combines three-dimensional scans with computer simulation to predict primary dental implant stability, the mechanical anchoring of an implant immediately after placement. The intended workflow is preoperative comparison of patient-specific implant choices within existing planning systems. The underlying simulation approach has also been used in industrial implant development, providing an early application beyond academic research.

Why BrainFocus stands out

For some people with drug-resistant epilepsy, seizures continue despite appropriate medication. Planning surgery can require specialist review of intracranial EEG, electrical recordings taken from electrodes placed inside or on the brain. BrainFocus is developing a way to organize these data into quantitative maps so clinical teams can identify likely seizure origins.

Its underlying localization algorithm achieved approximately 90% average sensitivity and specificity in a retrospective analysis of 30 patients.

What BrainFocus is building

BrainFocus produces analysis for presurgical assessment, including maps of the seizure onset zone, the brain area where seizures begin. The software aims to support specialist judgment rather than replace it. As a spinout associated with Universitat Politècnica de Catalunya and Universitat Pompeu Fabra, the startup combines university-origin methods with a hospital-facing clinical decision-support workflow.